I don’t think I’ve ever written about Profits Run before, but they have an ad running now that got me intrigued… mostly because I’m always curious about the “next Warren Buffett” and “next Berkshire Hathaway” teases we see from time to time. Here’s the intro that got my attention: “This ‘Shocking’ $4 Stock Could Hand […]
The “Trade War” is getting real, and the higher prices imposed by governments in China and the US. Tariffs are just import taxes, paid eventually by the customer, so they raise prices… which, our economist friends will tell us, suppresses demand… and since the higher price is going to a tax, not to a company, […]
“Forever battery,” “Jesus battery,” the “holy grail” of energy storage… those are all terms we’ve heard thrown around before, and in this instance they’re used by Matt McCall in service of his new pitch for his Investment Opportunities newsletter ($49/year for the “basic” version). And like other advances in batteries, of course, he thinks there’s […]
We seem to be on a bit of a dividend kick this week, with the “Extreme Dividends” of Monday leading to the “Secret 6.1% Stock” yesterday, so it seems natural to stock with it… plus, readers have been asking about Mark Skousen’s latest teaser pitch, and we haven’t covered him in a while. So that’s […]
Newsletter driven by “smart beta” strategy, includes both options and equity trades to leverage Skousen’s “Five Pillars of Profitability” (previously advertised as: Sales growth over 11%; Profit margins over 12%; Profit growth over 23%; Price-to-earnings ratio under 29; Major institutional buying)
Quick and dirty today, dear friends — I’m running short on time, so we’re jumping right into a simple teaser solution for a stock that a lot of people hate, and a lot of people have made a lot of money from. The ad I saw was from Tom Hutchinson, who is chief analyst of […]
This teaser solution was originally published in a Friday File for the Irregulars on November 30. The same ad is still circulating and several new folks have asked about it, so I’m releasing it for all to read today. What follows has not been updated since the end of November, and the ad is also […]
Time, once again, for the Annual Review of all of the stocks I hold in the Real Money Portfolio. Many of my positions are built up over many years, and sometimes they’re stocks that don’t generate a lot of news or attention for months at a time, so I promise each January to cover every […]
Here’s the lead-in that got Gumshoe readers banging on my door this week: “MAJOR ANNOUNCEMENT IMMINENT! SHOCKING PROPOSAL COULD IGNITE 59,850% SURGE “This serial entrepreneur guided his first company to a massive gain. And now, his latest venture has harnessed a patented technology that unlocks new $7 trillion energy sub-niche…” So even though this is […]
We’ve gotten similar “liberty check” pitches from Stephen Mauzy and Ian Wyatt in the past, but they always sound so very compelling and bring a lot of questions our way… so we’re looking at another ad today. I’m going off of a promo for a special “webinar” that they were hosting today, and I didn’t […]
This ad from Alex Koyfman is really bursting with hyperbole, and readers have been asking about it for close to a month now… so let’s see if we can get you some answers. After all, Alex Koyfman’s picture is right up there at the top of the ad with the inflammatory quote, “If I had […]
The first version of this article ran way back on March 30, 2016, so it might look familiar to a lot of you — but a few folks asked about it today, and it looks like the ad is running again, still without much change to the spiel, so I’m re-publishing this teaser solution. I’ve […]
It’s the beginning of the year, and that means we’re going to see lots and lots of “top stock for 2019” pitches — so, naturally, your friendly neighborhood Stock Gumshoe will be trying to solve ’em for you. There are two that caught my eye this Monday morning, the first was Alexander Green’s “No. 1 […]
This article was originally published on July 16, 2018, but questions continue to pile in and new ads out this week indicate that it’s also Alexander Green’s “top stock for 2019” … so we’re re-sharing it here. It has NOT been updated or revised since July, and the ad is also unchanged as far as […]
Happy New Year to the best readers in cyberspace! I hope your 2019 is fabulous… and that you don’t have too many heart palpitations following the last couple weeks of market and political brinksmanship. I haven’t written to you in a while, thanks to my much-appreciated time away with family and friends in the mountains, […]
Paul Mampilly’s high-end (~$5,000 one time fee plus $499 annual maintenance, no refunds) advisory that aims to “turn $10,000 into a $10 million fortune” — monthly stock picks with analytical commentary.
Ray Blanco makes (part of) his living looking for biotech moonshots, like most biotech-focused newsletter writers — and like his predecessor at Agora’s biotech and emerging tech-focused newsletter Breakthrough Technology Alert, he has often touted companies that are trying to end the scourge of Alzheimer’s Disease. Why? Well, two main reasons: First, and by far […]
We have a couple traditions here at Stock Gumshoe… we call out one of the worst teaser stock ideas around Thanksgiving and identify the “Turkey of the Year,” and then, as the year comes to a close and holiday merriment washes all around us, we call attention to the best teaser stocks of the year. […]
The response was pretty overwhelmingly positive when I started sending out those “Trade Note” emails this week… so I’ll stick with it for a while, at least, and see how this goes. What does that mean? Same day buy/sell notes about my Real Money Portfolio will be sent to the Irregulars going forward, in hopes […]
Scott Chan is pretty new to the world of newsletter pitchmen, but he’s apparently been working for Investing Daily for a while as a technology analyst, and is now headlining his second ad for them (that I’ve seen, at least). The last one was pitching a stem cell immunotherapy biotech stock (which hasn’t worked so […]